医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
17期
64-64
,共1页
CA199%胆红素%梗阻%肝胆疾病
CA199%膽紅素%梗阻%肝膽疾病
CA199%담홍소%경조%간담질병
CA199%Bilirubin%Obstruction%Hepatobiliary diseases
目的探讨CA199在良性梗阻性肝胆疾病患者血清中的变化及临床意义。方法对123例良性梗阻性肝胆疾病患者在入院和经治疗出院时分别进行血清CA199、总胆红素(TBil)、直接胆红素(DBil)、丙氨酸氨基移换酶(ALT)、天门冬氨酸氨基移换酶(AST)、碱性磷酸酶(ALP)检测，分析其变化。另设66名健康体检者作为对照组。结果病例组血清CA199、TBil、DBil、ALT、AST、ALP水平均显著高于对照组(<0.01)，经治疗CA199水平随TBil、DBil水平下降而下降，治疗前后CA199水平有显著差异(P<0.01)。结论在良性梗阻性肝胆疾病患者血清中CA199水平可明显增高。 CA199不能作为梗阻性肝胆疾病良恶性的判断依据，只有和其他指标联合应用才具临床意义。
目的探討CA199在良性梗阻性肝膽疾病患者血清中的變化及臨床意義。方法對123例良性梗阻性肝膽疾病患者在入院和經治療齣院時分彆進行血清CA199、總膽紅素(TBil)、直接膽紅素(DBil)、丙氨痠氨基移換酶(ALT)、天門鼕氨痠氨基移換酶(AST)、堿性燐痠酶(ALP)檢測，分析其變化。另設66名健康體檢者作為對照組。結果病例組血清CA199、TBil、DBil、ALT、AST、ALP水平均顯著高于對照組(<0.01)，經治療CA199水平隨TBil、DBil水平下降而下降，治療前後CA199水平有顯著差異(P<0.01)。結論在良性梗阻性肝膽疾病患者血清中CA199水平可明顯增高。 CA199不能作為梗阻性肝膽疾病良噁性的判斷依據，隻有和其他指標聯閤應用纔具臨床意義。
목적탐토CA199재량성경조성간담질병환자혈청중적변화급림상의의。방법대123례량성경조성간담질병환자재입원화경치료출원시분별진행혈청CA199、총담홍소(TBil)、직접담홍소(DBil)、병안산안기이환매(ALT)、천문동안산안기이환매(AST)、감성린산매(ALP)검측，분석기변화。령설66명건강체검자작위대조조。결과병례조혈청CA199、TBil、DBil、ALT、AST、ALP수평균현저고우대조조(<0.01)，경치료CA199수평수TBil、DBil수평하강이하강，치료전후CA199수평유현저차이(P<0.01)。결론재량성경조성간담질병환자혈청중CA199수평가명현증고。 CA199불능작위경조성간담질병량악성적판단의거，지유화기타지표연합응용재구림상의의。
Objective To investigate the changes of serum CA199 in patients with benign obstructive hepatobiliary diseases and its clinical significance. Methods The serum CA199,total bilirubin(TBil), direct bilirubin(DBil),alanine amino removed enzyme(ALT),aspartate amino removed enzyme(AST),the alkalinity phosphatase(ALP)of 123 patients with benign obstructive hepatobiliary diseases were detected when in hospital and after treatment out of hospital.Analysis of the changes.Set ing up 66 healthy physical examination as control group.Results The case group of serum CA199,TBil,DBil,ALT,AST,ALP levels were significantly higher than those in control group ( <0.01)After treatment with TBil and DBil decreased,the levels of CA199 decreased.The level of CA199 before and after treatment,there were significant dif erences ( <0.01).Conclusion The level of CA199 in serum of patients with benign obstructive hepatobiliary diseases can significantly increase.CA199 cannot be used as a judgment basis of benign and malignant obstructive hepatobiliary disease,Only joint detection with other indicators to be clinical significance.
